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Abstract
Background: Device-assisted enteroscopies (DAEs) are recent endoscopic techniques that enable direct endoscopic small-
bowel evaluation.
Objective: The objective of this article is to evaluate the implementation of DAEs in Portugal and assess the main indications,
diagnoses, diagnostic yield, therapeutic yield and complication rate.
Methods: We conducted a multicenter retrospective series using a national Web-based survey on behalf of the Portuguese
Small-Bowel Study Group. Participants were asked to fill out two online databases regarding procedural data, indications,
diagnoses, endoscopic therapy and complications using prospectively collected institutional data records.
Results: A total of eight centers were enrolled in the survey, corresponding to 1411 DAEs. The most frequent indications were
obscure gastrointestinal bleeding (OGIB), inflammatory bowel disease and small-bowel tumors. The pooled diagnostic yield
was 63%. A relation between the diagnostic yield and the indications was clear, with a diagnostic yield for OGIB of 69%
(p¼ 0.02) with a 52% therapeutic yield. Complications occurred in 1.2%, with a major complication rate of 0.57%.
Perforations occurred in four patients (0.28%).
Conclusion: DAEs are safe and effective procedures, with complication rates of 1.2%, the most serious of which is perfor-
ation. Most procedures are performed in the setting of OGIB. Diagnostic and therapeutic yields are dependent on the
indication, hence appropriate patient selection is crucial.
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Introduction
In recent years, two major innovations revolutionized
small-bowel endoscopic exploration: capsule endoscopy
(CE) and deep enteroscopy. CE was developed in 20011
and rapidly evolved as the ideal technique for the endo-
scopic evaluation of small-bowel pathology, as it is a
safe, easy and noninvasive technique that enables com-
plete small-bowel visualization. However, it has some
major limitations, mostly lack of movement control
and therapeutic capabilities. Deep enteroscopy, on the
other hand, allows direct endoscopic visualization and
control, as well as most diagnostic and therapeutic
endoscopic techniques. The concept of deep
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enteroscopy was introduced with the development of
double-balloon enteroscopy (DBE) in 2003 by
Yamamoto et al.2 Soon, single-balloon enteroscopy3
(SBE) and spiral enteroscopy4 (SE) were also intro-
duced. These techniques are grouped under the desig-
nation of device-assisted enteroscopy (DAE).
The experience with DAE mostly relies on single-
center series from experienced referral centers, and
on multicenter studies also usually from referral cen-
ters focusing on speciﬁc pathologies or technical
comparisons. There is limited evidence on the
national use of DAEs in the community, particularly
in Portugal.
Hence, the authors aimed to evaluate the
Portuguese experience with DAEs, focusing on two
diﬀerent aspects: technical ones, related to the equip-
ment, logistics and training capabilities; and clinical
ones such as indications, diagnoses, therapeutic pro-
cedures, diagnostic and therapeutic yield and
complications.
Methods
We conducted a multicenter retrospective descriptive
study of medical centers performing DAEs in
Portugal. A national survey of centers performing
DAEs was performed, on behalf of the Portuguese
Small-Bowel Study Group (GEPID—‘‘Grupo de
Estudos Portugueˆs do Intestino Delgado’’), a section
of the Portuguese Society of Gastroenterology
(SPG—‘‘Sociedade Portuguesa de Gastrenterologia’’).
A formal invitation letter to participate in the
study was sent from the SPG to all Portuguese gastro-
enterology departments. This invitation letter
explained the nature of the multicenter survey and the
purpose of data collection. The invitation letter also
contained links to two online questionnaires for data
collection.
Questionnaires
Centers enrolled in the survey were asked to ﬁll out two
online questionnaires. The links sent in the invitation
letter gave access to online forms for which only data
entry was possible. The deadline for data entry was set
to May 7, 2014. Participants were not able to see the
questionnaires from other centers. Patients were
inserted anonymously by the participants entering
data. Access to the database was granted only to inves-
tigators directly involved in data analysis.
The ﬁrst questionnaire (Form #1) aimed to charac-
terize individual centers performing DAEs and the
second questionnaire (Form #2) aimed to collect data
from individual patients undergoing DAEs in each
center (Table 1).
DAE procedures
Participants were invited to include all procedures per-
formed until the deadline for data inclusion. All DAE
procedures were performed according to each institu-
tion’s individual protocol, reﬂecting standard community
practice. Each patient gave informed consent for DAE,
complementary diagnostic and therapeutic procedures
and sedation. The survey was approved by the ethics
committees and both the SPG and GEPID boards.
Statistical analysis
Data from the online forms were exported as an
‘‘.xls’’-ﬁle spreadsheet and imported to SPSS v19.0 for
data analysis. Data were reviewed for homogeneity,
and inconsistencies and some answers were grouped
into diﬀerent categories when appropriate.
Descriptive statistics were used to summarize data:
Fisher’s exact test to compare discrete variables (diag-
nostic yield, complications); Spearman’s correlation
coeﬃcient to correlate the satisfaction score with the
total number of procedures; and the Mann-Whitney
test was used to compare the satisfaction score with
the type of enteroscope.
Results
Individual centers and DAE techniques
Eight centers, from 11 centers performing DAE in
Portugal, agreed to participate in the survey and
answered the online forms (Table 2). All centers are
located in the Northern region of Portugal, except for
one center in the Central and one center in the Southern
regions. Five centers used exclusively SBE, two centers
exclusively DBE and one center both DBE and SE. One
center performing DBE used the diagnostic enteroscope
(EN-450P5/20) and the remaining the therapeutic
enteroscope (EN-450T5). One of these centers recently
upgraded their DBE to the new EN-580T. Only one of
the responding centers (ManopH-ICUF) is located in
an outpatient facility and the remaining are hospital-
based centers.
Two of these centers started DAEs in 2005, one in
2007, 2008, 2009, 2010 and two in 2013. The ﬁrst three
centers implementing DAEs adopted DBE and all the
remaining centers from 2008 onward selected SBE.
A total of 23 endoscopists have performed DAEs in
these eight centers. Currently, 20 of them routinely per-
form DAEs, ranging from two to three in each center.
Use of DAE
Only three of the eight centers declared using DAE in
the emergency setting for active OGIB.
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Half (n¼ 4) of the centers reported using the entero-
scope for other purposes than small-bowel enteroscopy
(ManopH-ICUF, CHGE, CHUC and HPH), mainly to
perform diﬃcult colonoscopies and push enteroscopies.
Only two centers (CHGE and HPH) reported its use to
perform endoscopic retrograde colangiopancreatogra-
phy (ERCP) in patients with surgically altered
anatomy.
Table 2. Summary of the characteristics of individual centers
Center Region
Type
of
DAE
Start
of
DAE
Number of
procedures
Number of
procedures/
month
Number of
endoscopists
performing
DAE
Availability of
fluoroscopy
Satisfaction
score
Training of
fellows
Training of
specialists
ManopH-ICUF North DBE, SE 2005 528 4.7 2 No 7 4 2
CHUC Center DBE 2005 215 1.9 3 No 6 5 1
IPOLFG South DBE 2007 316 4.0 2 No 6 5 2
CHAA North SBE 2008 25 0.4 3 No 7 4 –
CHGE North SBE 2009 155 2.9 2 No 8 6 4
CHSJ North SBE 2010 135 2.9 3 Yes 7 3 –
HPH North SBE 2013 21 1.4 2 No 3 – –
CHP North SBE 2013 13 1.3 2 Yes 5 – –
ManopH-ICUF: ManopH, Instituto CUF, Porto; CHUC: Centro Hospitalar da Universidade de Coimbra; IPOLFG: Instituto Portugueˆs de Oncologia de Lisboa,
Francisco Gentil; CHAA; Centro Hospitalar do Alto Ave; CHGE: Centro Hospitalar de Vila Nova de Gaia/Espinho; CHSJ: Centro Hospitalar de Sa˜o Joa˜o; HPH:
Hospital Pedro Hispano; CHP: Centro Hospitalar do Porto; DAE: device-assisted enteroscopy; DBE: double-balloon enteroscopy; SBE: single-balloon
enteroscopy; SE: spiral enteroscopy.
Table 1. Questionnaires sent to gastroenterology departments performing device-assisted enteroscopy in Portugal
Form #1
- Names of individual physicians performing DAE in your center
- Type of DAE used (DBE, SBE or SE).
- The date when DAE was started in your center
- Number of procedures preceded by CE
- Number of urgent procedures for active small-bowel bleeding
- Number of therapeutic procedures
- Number of procedures where the purpose of the examination was considered fulfilled
- Degree of satisfaction with the technique
- Use of DAE for procedures other than small-bowel enteroscopy
- Availability of fluoroscopy in the examination room
- Availability of an anesthesiology team during the procedure
- Type of sedation used: mild sedation, deep sedation, general anesthesia
- Training capacity for residents or specialists from other centers without experience in DAE
Form #2:
- Anonymous patient identification
- Age
- Sex
- Indication for DAE
- Type of DAE used (DBE, SBE or SE).
- Route of insertion
- Depth of insertion
- Reason to interrupt the progression
- Duration of the procedure
- Type of sedation
- Diagnosis
- Additional diagnostic or therapeutic procedures performed during DAE
- Complications
- Identification of the physician filling the questionnaire
DAE: device-assisted enteroscopy; DBE: double-balloon enteroscopy; SBE: single-balloon enteroscopy; SE: spiral enteroscopy; CE: capsule endoscopy.
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Satisfaction with DAE was evaluated on a subjective
analog scale ranging from 0 (no satisfaction) to 10
(complete satisfaction). The median satisfaction score
was 6.5 ranging from 3 to 8 and was not correlated with
the total number of procedures (p¼ 0.3) or the type of
enteroscope used (p¼ 0.9).
Only two centers (CHSJ and CHP) have ﬂuoroscopy
available in the examination room used to perform
DAEs, although all centers (except ManopH-ICUF)
have ﬂuoroscopy available in other locations on
request.
All participating centers declared having an anes-
thesiologist during the procedure. In all centers, most
cases were performed under deep sedation with pro-
pofol without orotracheal intubation. In three cen-
ters, 24 (1.7%) patients were examined under
general anesthesia and in one center, 55 (3.9%)
patients were examined under mild midazolam
sedation.
Regarding the capacity to train gastroenterology
fellows and specialists from other centers without
experience in DAE, six centers reported training cap-
acity. The two centers whose activity started only in
2013 declared no training capacity at their current
stage. A total of 27 gastroenterology fellows have
already been trained in DAE in the six centers
with training capacity. A total of ﬁve centers have
already trained nine gastroenterology specialists from
other centers (CHGE: four, ManopH-ICUF: two,
IPOLFG: two and CHUC: one).
Case series
A total of 1411 cases were recorded in the online Form
#2, from the eight participating centers. From these,
1054 were DBE, 351 SBE and six SE.
The mean age was 57.6 years (SD 18.3), ranging
from 9 to 98 years old. Males accounted for 53.3% of
patients. Of the 1411 procedures, 16 (1.1%) were pedi-
atric patients (<18 years old) and 567 (40.2%) were
elderly patients ( 65 years old).
The indications for DAE are summarized in Table 3.
As expected, the main indications were OGIB, sus-
pected/conﬁrmed small-bowel inﬂammatory bowel dis-
ease and suspected small-bowel tumors.
The route of insertion according to the diﬀerent
types of DAE and indications is detailed in Table 3.
Predictably, the oral route of insertion was more fre-
quently used with all DAE techniques.
Total enteroscopy was rarely attempted as the goal
of most procedures was dictated by the ﬁndings of a
previous examination, mostly CE (n¼ 1033, 73.2%).
The rate of total enteroscopy could not be determined
as the database was not designed to evaluate the limit
of insertion in the uncommon procedures in which it
was attempted. However, total enteroscopy was
reported in 22 procedures (DBE: 19, SBE: two,
SE: one).
The main diagnoses established in each enteroscopy
according to the type of DAE and the route of insertion
are detailed in Table 4. No signiﬁcant ﬁndings were
established in 37.1% of patients. As expected from
other case series, angiectasias, Crohn’s disease and
tumors/polyps were the most frequent diagnoses,
accounting for 43.8% of all diagnoses.
The diagnostic and therapeutic procedures per-
formed during DAEs according to the type of DAE
used are detailed in Table 5. In 595 (42.2%) patients
no additional endoscopic procedures other than occa-
sional tattooing were performed and in 380 (26.9%) of
patients only biopsies were taken. Therapeutic proced-
ures were performed in 436 (30.9%) patients.
As detailed in Table 4, argon-plasma coagulation and
polypectomy represented the most frequently used
therapeutic techniques.
The diagnostic and therapeutic yield according to
the indication is detailed in Table 6. A pooled diagnos-
tic yield for all indications of 63% was found.
Compared to this pooled diagnostic yield, the diagnos-
tic yield was higher for anemia/OGIB (69%, p¼ 0.02),
Peutz-Jeghers Syndrome (PJS) (95%, p< 0.0001) and
familial adenomatous polyposis (FAP)/MUTYH-asso-
ciated polyposis (MAP) (100%, p¼ 0.009) and lower
for suspected tumors (52%, p¼ 0.001), abnormal radio-
logic studies (42%, p¼ 0.04) and miscellaneous less-fre-
quent indications (40%, p< 0.0001).
Major complications are reported in Table 7.
Anesthetic complications requiring interruption of the
procedures were reported in nine (0.6%) patients, all
under deep propofol sedation, six of them age 65 or
older (p> 0.05) and seven of them performing oral
DAEs (p> 0.05). Perforation was reported in 0.28%,
including one diagnostic procedure in a patient with
radiation enteritis and three therapeutic procedures: a
balloon-dilation, argon-plasma coagulation of an
angiectasia and a direct percutaneous endoscopic jeju-
nostomy (DPEJ).5 In a patient with PJS undergoing
polypectomy of a large polyp, snare entrapment
occurred during polypectomy requiring surgical
intervention.
Discussion
This is the ﬁrst audit ever performed to evaluate the
practice of DAE in Portugal. Although the study was
extended to all Portuguese centers, a small fraction
declined to participate. However, all centers with the
most experience and greater casuistic were enrolled,
allowing the results to be representative of the national
experience.
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DAE was introduced early in Portugal, shortly after
the description of the procedure. In 2005, two centers
were already performing the technique and, a few years
later, DAE was introduced in a larger number of cen-
ters. The later widespread dissemination consisted
mostly of SBE, as in Portugal a greater proportion of
endoscopy centers use Olympus equipment, hence lim-
iting acquisition costs to the enteroscope itself.
According to the organization of the Portuguese
national health system, most enteroscopy centers are
Table 3. Indications for DAE, according to the type of DAE and route of insertion
Indications DBE SBE SE Total
Global
Anemia/OGIB 436 120 4 560
Suspected tumor 189 48 1 238
Suspected IBD 121 55 – 176
Confirmed IBD 88 26 1 115
Polyp(s) 9 27 – 36
PJS 69 4 – 73
FAP/MAP 10 1 – 11
Stenosis 19 12 – 31
Abnormal radiologic studies 14 12 – 26
Malabsorption syndromes 18 12 – 30
Other 81 34 – 115
Total 1054 351 6 1411
Oral route of insertion
Anemia/OGIB 361 (4 a) 90 (4 a) 4 455
Suspected tumor 139 (1 a) 36 (2 a) 1 176
Suspected IBD 73 (2 a) 25 (3 a) 0 98
Confirmed IBD 45 7 1 53
Polyp(s) 9 (1 a) 24 0 33
PJS 65 3 0 68
FAP/MAP 9 1 0 10
Stenosis 13 7 0 20
Abnormal radiologic studies 11 11 0 22
Malabsorption syndromes 16 7 0 23
Other 58 (1 a) 28 0 86
Total 799 239 6 1044
Anal route of insertion
Anemia/OGIB 75 30 – 105
Suspected tumor 50 12 – 62
Suspected IBD 48 30 – 78
Confirmed IBD 43 19 – 62
Polyp(s) – 3 – 3
PJS 4 1 – 5
FAP/MAP 1 – – 1
Stenosis 6 5 – 11
Abnormal radiologic studies 3 1 – 4
Malabsorption syndromes 2 5 – 7
Other 23 6 – 29
Total 255 112 – 367
aNumber of patients in whom oral and anal DAE was performed the same day. These procedures are recorded as a single procedure, and detailed in the
oral route of insertion section. DAE: device-assisted enteroscopy; SBE: single-balloon enteroscopy; SE: spiral enteroscopy; OGIB: obscure gastrointestinal
bleeding; IBD: inflammatory bowel disease; PJS: Peutz-Jeghers syndrome; FAP: familial adenomatous polyposis; MAP: MUTYH-associated polyposis.
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Table 4. Main diagnostic finding established in all enteroscopies according to the route of insertion and type of
enteroscope used
Diagnosis DBE SBE SE Total
Oral route of insertion
Normal 284 (5 a) 78 (1 a) 1 363
Vascular lesion(s) 216 63 4 283
 Angiectasia(s) 206 57 (2 a) 4 267
 Dieulafoy 2 3 – 5
 Active bleeding 6 (1 a) – – 6
 Portal hypertensive enteropathy 2 3 (1 a) – 5
Inflammatory lesion(s) 95 25 1 121
 Crohn’s disease 35 13 (1 a) 1 49
 Non-specific enteritis 34 (2 a) 12 – 46
 Celiac disease 14 - – 14
 NSAIDs enteropathy 9 - – 9
 Radiation enteritis 3 - – 3
Polyps/polyposis 92 26 – 118
 PJS 64 2 – 66
 FAP/MAP 9 1 – 10
 Polyp(s) 19 (1 a) 23 (1 a) – 42
Tumor 62 9 (1 a) – 71
Stenosis 12 11 (1 a) – 23
Extra-small-bowel findings 10 – – 10
Other findings 28 27 (1 a) – 55
Total 799 239 6 1044
Anal route of insertion DBE SBE SE Total
Normal 122 39 – 161
Inflammatory lesion(s) 63 43 – 106
 Crohn’s disease 34 35 – 69
 Non-specific enteritis 25 6 – 31
 Radiation enteritis 2 2 – 4
 NSAIDs enteropathy 1 – – 1
 Celiac disease 1 – – 1
Vascular lesion(s) 17 4 – 21
 Angiectasia(s) 16 4 – 20
 Active bleeding 1 - - 1
Stenosis 9 6 – 15
Extra-small bowel findings 11 2 – 13
Polyps/polyposis 10 3 – 13
 PJS 2 1 – 3
 FAP/MAP 1 – – 1
 Polyp(s) 7 2 – 9
Tumor 9 2 – 11
Other findings 14 13 – 27
Total 255 112 – 367
All patients
Normal 406 117 1 524
Vascular lesion(s) 233 67 4 304
(continued)
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public inpatient facilities. In each center, two or three
endoscopists are dedicated to performing DAEs. The
rate of complete enteroscopy, diagnostic and thera-
peutic yields and the complication rate of DBE and
SBE were compared in two recent meta-analyses.6,7
They were found to be comparable regarding all aspects
except the rate of complete enteroscopy, which was
found to be slightly higher with DBE. This is, however,
Table 4. Continued
Diagnosis DBE SBE SE Total
 Angiectasia(s) 222 61 4 287
 Active bleeding 7 – – 7
 Dieulafoy 2 3 – 5
 Portal hypertensive enteropathy 2 3 – 5
Inflammatory lesion(s) 158 68 1 227
 Crohn’s disease 69 48 1 118
 Non-specific enteritis 59 18 – 77
 Celiac disease 15 – – 15
 NSAIDs enteropathy 10 – – 10
 Radiation enteritis 5 2 – 7
Polyp(s)/polyposis 102 29 – 131
 PJS 66 3 – 69
 FAP/MAP 10 1 – 11
 Polyp(s) 26 25 – 51
Tumor 71 11 – 82
Stenosis 21 17 – 38
Extra-small bowel findings 21 2 – 23
Other findings 42 40 – 82
Total 1054 351 6 1411
aNumber of patients in which oral and anal DAE was performed the same day. These procedures are recorded as a single procedure, and
detailed in the oral route of insertion section. DAE: device-assisted enteroscopy; SBE: single-balloon enteroscopy; SE: spiral enteroscopy;
NSAIDs: nonsteroidal anti-inflammatory drugs; PJS: Peutz-Jeghers syndrome; FAP: familial adenomatous polyposis; MAP. MUTYH-associated
polyposis.
Table 5. Diagnostic and therapeutic procedures performed during DAE. Only one technique is reported per procedure. In some cases,
more than one technique has been used – for instance, in procedures where polypectomy has been performed, injection and tattooing
could also have been used
Procedures DBE SBE SE Total
None/tattooing 461 130 4 595
Only biopsies 271 109 – 380
Hemostatic/ablative therapies 235 64 1 300
 Argon plasma coagulation 210 57 1 268
 Only adrenaline injection 20 2 – 22
 Hemostatic clips 5 5 – 10
Polypectomy 72 24 – 96
Balloon dilation 6 10 1 17
Foreign body removal 9 5 – 14
DPEJ – 8 – 8
Stenting – 1 – 1
Total 1054 351 6 1411
DAE: device-assisted enteroscopy; SBE: single-balloon enteroscopy; SE: spiral enteroscopy; DPEJ: direct percutaneous endoscopic jejunostomy.
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of arguable clinical signiﬁcance as the goal of each
examination can usually be reached using both tech-
niques, as expected by their similar diagnostic and
therapeutic yields.
The use of DAE in the emergency setting is still
uncommon. This may result from organizational diﬃ-
culties, as the two or three endoscopists experienced in
DAEs in each center may not be assigned to emergency
procedures at that time; and logistical obstacles, since
the procedure is time and resource consuming requiring
a long allotment of time and signiﬁcant staﬀ including
an anesthesiologist, for the entire duration of the pro-
cedure. Furthermore, in some centers CE is not rou-
tinely performed in the emergency setting to guide the
use of DAE. This has important clinical implications
since the use of CE and DAE8 early in the presentation
of overt OGIB improves both the diagnostic and thera-
peutic yields.
Only half the centers involved reported the use of
DAE for purposes other than small-bowel evaluation
and only 25% reported its use for ERCP (DAE-ERCP)
in patients with surgically modiﬁed anatomy. This may
be explained in part by the diﬀerent areas of expertise
of endoscopists performing DAE, as most of them may
not be proﬁcient in other techniques such as ERCP.
DAE-ERCP enables access to the biliary system and
most conventional biliary therapeutics in the great
majority of this subset of patients.9–11 Nevertheless, it
is very demanding, time consuming, and limited by the
availability of speciﬁc accessories,12 which also adds
technical and logistic diﬃculties to its widespread
implementation.
Only two centers rated the subjective satisfaction
with DAE with a score equal to or below 5 (0–10).
In these two centers the technique was introduced in
the year previous to the survey, hence these centers
had performed a limited number of procedures
(13 and 21). The remaining centers rated the satisfac-
tion between 6 and 8, probably reﬂecting greater
experience, although a correlation between the satis-
faction score and the total number of procedures was
not found.
Table 6. Diagnostic and therapeutic yield according to the indication
Indication
Diagnostic yield
(DY), n/%
p (compared with
pooled DY)
Therapeutic
yield n/% Patients, n
Anemia/OGIB 384/69% 0.02 289/52% 560
Suspected tumor 123/52% 0.001 – 238
Suspected IBD 101/57% 0.2 – 176
Confirmed IBD 82/71% 0.09 – 115
Polyp(s) 22/61% 0.9 11/31% 36
PJS 69/95% <0.0001 51/70% 73
FAP/MAP 11/100% 0.009 6/55% 11
Stenosis 19/61% 0.8 – 31
Abnormal radiologic studies 11/42% 0.04 – 26
Malabsorption syndromes 19/63% 1.0 – 30
Other 46/40% <0.0001 – 115
All indications 887/63% – 1411
OGIB: obscure gastrointestinal bleeding; IBD: inflammatory bowel disease; PJS: Peutz-Jeghers syndrome; FAP: familial adenomatous polyposis; MAP:
MUTYH-associated polyposis.
Table 7. Complications of device-assisted enteroscopy
Complications DBE (n/%) SBE (n/%) SE (n/%) Total (n/%)
Anesthetic complicationsa 9/0.85% – –/– 9/0.64%
Perforation 3/0.28% 1/0.28% –/– 4/0.28%
Pancreatitis 2/0.19% –/– –/– 2/0.14%
Post-polypectomy syndrome –/– 1/0.28% –/– 1/0.07%
Snare entrapment 1/0.09% –/– –/– 1/0.07%
Total 14/1.33 % 2/0.57% –/– 17/1.20%
a6-Oxygen desaturation, 2-persistent bradycardia; 1-vomiting. DBE: double-balloon enteroscopy; SBE: single-balloon enteroscopy; SE: spiral enteroscopy.
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Signiﬁcant ﬁndings were found in 63% of patients, a
diagnostic yield similar to a recent systematic review13
of 12,823 DBEs in which a pooled diagnostic yield of
68.1% was found. In this review, the most frequent
ﬁndings were inﬂammatory lesions (either Crohn’s dis-
ease or non-speciﬁc inﬂammatory lesions), vascular
lesions and tumoral lesions (either benign or malig-
nant). In our series these were also the most frequent
ﬁndings, accounting for 84% (745/887) of all positive
ﬁndings and 52.8% of all diagnoses (745/1411). This
high rate of positive ﬁndings is derived from the fact
that DAE is considered a secondary procedure after an
initial positive diagnostic test, as recommended by cur-
rent European guidelines.14
Small-bowel polyposis syndromes accounted for 6%
(84/1411) of the examinations. Most (86.9%; 73/84)
consisted of PJS referred for endoscopic polypectomy
of polyps larger than 10mm detected in surveillance
CE. Snare entrapment in a large polyp was reported
in one procedure (1.4%), requiring surgical interven-
tion to remove the snare and resect the polyp. No per-
forations were recorded after polypectomy in contrast
to high rates of post-polypectomy perforations previ-
ously reported in PJS.15,16 A multicenter series of 46
procedures comprising a survey wherein polypectomy
was performed was recently published,17 in which 214
polyps with a median size of 30mm were removed. In
six of these 46 procedures, surgical intervention was
required (jejunal neoplasia: one case, polyps locally
concentrated in large numbers: two cases, bulky
polyps: two cases with a size up to 60mm and invagi-
nated polyp: one case). All remaining polyps were man-
aged endoscopically.
DAE is frequently used for therapy of small-bowel
lesions detected in other procedures.14,18–20 This is
reﬂected in a high percentage of therapeutic procedures
(30.9%). As expected from the main indications and
other series,13,15,18,21 hemostatic therapies, namely
argon-plasma coagulation, were the most frequently
employed endoscopic therapies. Polypectomy, fre-
quently in the setting of PJS, was also commonly
performed.
The diagnostic yield was high in all indications,
reﬂecting an appropriate patient selection, since in
most cases DAE followed a positive CE as in other
series.18 In patients with OGIB, the most frequent indi-
cation for CE and DAE,13,16,22,23 the diagnostic yield
was 69%, similar to other series,15,21 and the thera-
peutic yield was also high at 52%. In patients with
polyposis syndromes, the diagnostic yield was near
100% (95% and 100% for PJS and FAP/MAP) and
the therapeutic yield was also high (70% for PJS and
55% for FAP/MAP). Although not directly evaluated
in the present study, since in Portugal the surveillance
of these patients is typically performed with CE these
data also point to a good accuracy of CE for screening
these patients. Although several reports show that
CE24,25 and cross-sectional radiological modalities26
may miss signiﬁcant mass lesions, both have a role
for small-bowel screening.25,27
The diagnostic yield for suspected small-bowel
tumors (52%) was below the pooled diagnostic yield
(p¼ 0.001). Although DAE is regarded as the gold
standard for the diagnosis of small-bowel tumors,28
this lower diagnostic yield reﬂects a signiﬁcant portion
of false-positive tumors in CE, probably resulting from
bulges due to compressions from adjacent organs or
bowel loops.29
Most examinations were performed under anesthe-
siologist-administered propofol sedation, a common
practice in deep sedation for endoscopic procedures in
Portugal.30 Anesthetic complications occurred in 0.6%
of DAEs and consisted mainly of oxygen-desaturation
and less frequently bradycardia and vomiting. All cases
were reversed after the interruption of the procedure.
Minor oxygen desaturation not requiring the interrup-
tion of the procedure was not regarded as a complica-
tion. In a recent study, Lara et al.31 reported anesthetic
adverse events in 15 of 432 procedures (3.5%) per-
formed under deep sedation, mostly oxygen desatur-
ation. Based on this high rate of anesthetic adverse
events, the authors currently perform endotracheal
intubation for antegrade DAEs. However, this seda-
tion-related complication rate is superior to previous
reports.15,32 A recent large multicenter study from
Germany, a country where non-anesthesiologist propo-
fol-sedation is common practice, reported 11 (0.5%)
sedation-related adverse events in 2245 procedures.15
No more sedation-related adverse events were found
in elderly patients, as previously reported.33
Complications were reported in 1.2% (17/1411),
similar to the multicenter German study15 in which a
complication rate of 1.2% (27/2245) was also found.
Major complications were reported in 0.57% (eight of
1411), similar to a recent systematic review where major
complications where reported in 0.72% of examin-
ations.13 Only two cases of acute pancreatitis were rec-
orded. However, this complication is probably
underreported, as it occurs frequently several hours
after the procedure and most centers perform DAEs
for patients from other institutions. Perforation
occurred in four patients (0.28%), most of them after
therapeutic procedures, as previously reported.15,16
The authors acknowledge some limitations.
Although all centers enrolled in the survey maintained
prospective data records of all procedures, the data-
bases were not designed for this survey. Consequently
some minor variations in data collection, registration
and follow-up may have occurred. One participant at
each institution compiled the database. Although it was
Pinho et al. 9
a simple database and the required ﬁelds were easy to
follow, some inconsistencies in the records may have
occurred. However, the database was checked for pos-
sible inconsistencies by two authors (RP, MMS). Most
centers perform procedures for other institutions and
the institution with the highest volume is an outpatient
center performing procedures exclusively for other
institutions. Hence patient follow-up and recording of
delayed complications such as acute pancreatitis may
be compromised.
Conclusions
This is the ﬁrst published survey on the use of DAEs in
Portugal. It shows that DAE is widely available in
Portugal, mostly in Northern centers, with good per-
formance and training capabilities. Earlier centers
adopted DBEs whereas the centers that recently intro-
duced DAE elected SBE. The diagnostic and thera-
peutic yields are high as most procedures were
performed to manage abnormalities detected in other
examinations, mostly CE. The complication rate is low,
mostly anesthetic complications promptly reversed
after the interruption of the procedure. Perforations
are rare (0.28%) and occur mainly in therapeutic
procedures.
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